Juan Carlos Borrego

Hospital General De Zona — Mexico

Neuroscience · Life Sciences

7h-index260citations14works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tryptophan and brain disorders(5), COVID-19 Clinical Research Studies(4), Metabolomics and Mass Spectrometry Studies(4), Long-Term Effects of COVID-19(4), Gut microbiota and health(2)

Publications14 total

Risks, complications, and protective factors for health in pregnant adolescent workers in agricultural fields
Journal of Family Medicine and Primary Care·2025Open Access
Comprehensive clinical and metabolomics profiling of COVID-19 Mexican patients across three epidemiological waves
Frontiers in Molecular Biosciences·2025· 1 citedOpen Access
Perspective Chapter: Diabetes as a Post-COVID Syndrome – Possible Mechanisms Involved
IntechOpen eBooks·2025Open Access
Quiste dermoide de ovario con presentación atípica juvenil: reporte de caso clínico
Revista Pediátrica de Panamá·2024
Acute Kidney Injury in the Context of COVID-19: An Analysis in Hospitalized Mexican Patients
Infectious Disease Reports·2024· 3 citedOpen Access
The plasma metabolome of long COVID patients two years after infection
Scientific Reports·2023· 86 citedOpen Access
The plasma metabolome of long COVID-19 patients two years after infection
2023· 8 citedOpen Access
Untargeted analysis in post-COVID-19 patients reveals dysregulated lipid pathways two years after recovery
Frontiers in Molecular Biosciences·2023· 31 citedOpen Access
COVID-19 Outcome Prediction by Integrating Clinical and Metabolic Data using Machine Learning Algorithms
Revista de investigaci�n Cl�nica·2022· 7 citedOpen Access
Author Correction: Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19
Scientific Reports·2022Open Access
Kynurenine and Hemoglobin as Sex-Specific Variables in COVID-19 Patients: A Machine Learning and Genetic Algorithms Approach
Diagnostics·2021· 7 citedOpen Access
Immunometabolic signatures predict risk of progression to sepsis in COVID-19
PLoS ONE·2021· 46 citedOpen Access
Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19
Scientific Reports·2021· 68 citedOpen Access
Targeted Metabolomics Identifies High Performing Diagnostic and Prognostic Biomarkers for COVID-19
Research Square (Research Square)·2021· 3 citedOpen Access

Frequent Co-authors

Yamilé López‐Hernández(10), Jesús Adrián López(10), Joel Monárrez‐Espino(8), Jiamin Zheng(7), Rupasri Mandal(7), David S. Wishart(7), Juan José Oropeza-Valdez(7), Julio Enrique Castañeda‐Delgado(4), David Alejandro García López(3), Claudia Torres-Calzada(3), José Antonio Enciso Moreno(3), Ana Sofía Herrera-Van Oostdam(3), José Pedro Elizalde-Díaz(2), Mark Berjanskii(2), Eduardo Martínez‐Martínez(2), Lun Zhang(2), Fátima de Lourdes Ochoa González(2), Flor M. Trejo-Medinilla(2), Julio C. Fernández-Ruiz(2), Fátima de Lourdes Ochoa-González(2)